I am a urologist specializing in urologic oncology. My research focuses primarily on developing new therapies for bladder cancer and identification and treatment of aggressive types of prostate cancer.
I obtained my medical training at Northwestern University (Feinberg School of Medicine, Chicago, Illinois) and completed my surgical residency in urology at Johns Hopkins (Baltimore, Maryland). Subsequently, I completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center (Houston, Texas).
In addition to performing research, which has been published in numerous peer-reviewed journals, I also serve as an editor for BMC Cancer and a reviewer for European Urology, Urologic Oncology, Journal of Urology and PLoS ONE. While I was at Johns Hopkins, I received the Frank L. Coulson, Jr., Award for Clinical Excellence, and my research in prostate cancer was recognized by ASCO in 2013 as one of the ‘Clinical Cancer Advances’ of the year. While I was at MD Anderson, I received the Conquer Cancer Foundation of ASCO Merit Award and the William L. Pippin Endowed Fellowship for my work in bladder cancer research.
Treatment for urologic cancers can include multiple treatment choices, and I enjoy getting to know my patients and their priorities to determine the best care plans for each individual patient. The OSUCCC – James is an incredible place. A direct benefit of the cutting-edge research and technology here is that I can offer my patients state-of-the-art treatment strategies and surgical options that maximize safety and precision. I am proud to be a member of The James, and to be part of the process that lifts oncology care to such heights is a true honor.